Watchlist Price Alert

Connect Biopharma Limite... (CNTB)

NASDAQ: CNTB · Real-Time Price · USD

1.06

0.08 (8.17%)

At close: Jun 17, 2025, 3:59 PM

1.08

1.85%

After-hours: Jun 17, 2025, 07:32 PM EDT

Connect Biopharma Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q4 2024	Q2 2024	Q4 2023	Q2 2023	Q4 2022	Q2 2022	Q4 2021	Q2 2021	Q4 2020	Q4 2019	Q2 2019	Q4 2018
Period Ending	Dec 31, 2024	Jun 30, 2024	Dec 31, 2023	Jun 30, 2023	Dec 31, 2022	Jun 30, 2022	Dec 31, 2021	Jun 30, 2021	Dec 31, 2020	Dec 31, 2019	Jun 30, 2019	Dec 31, 2018
Cash & Equivalents	78.23M	110.17M	106.01M	81.39M	80.37M	141.56M	268.02M	313.13M	154.73M	44.82M	53.08M	61.34M
Short-Term Investments	15.48M	67K	12.65M	49.82M	74.67M	49.34M	n/a	n/a	2M	4.44M	2.41M	371.01K
Long-Term Investments	n/a	n/a	n/a	n/a	9.6M	22.33M	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	33K	96K	132K	735.53K	34.62K	72.36K	2.9M	2.06M	1.57M	921.82K	823.75K	725.68K
Receivables	1.05M	3.85M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	-13.95M	3.48M	3.18M	6.7M	n/a	n/a	n/a	3.18M	1.59M	n/a
Other Current Assets	53K	n/a	n/a	3.1M	n/a	1.11M	n/a	1.13M	n/a	n/a	206.75K	413.5K
Total Current Assets	96.96M	115.9M	120.97M	137.81M	158.46M	198.04M	275.44M	324.4M	161.89M	52.64M	60.36M	68.08M
Property-Plant & Equipment	4.24M	4.52M	4.73M	5.09M	5.47M	10.76M	9.5M	6.18M	2.68M	496.45K	488.03K	479.61K
Goodwill & Intangibles	53K	57K	62K	64.59K	3.22M	3.33M	3.54M	3.48M	52.39K	n/a	n/a	n/a
Total Long-Term Assets	4.32M	4.67M	4.92M	5.89M	18.55M	36.98M	15.94M	11.72M	4.3M	1.42M	1.31M	1.21M
Total Assets	101.28M	120.57M	125.89M	143.7M	177.01M	235.02M	291.39M	336.12M	166.19M	54.05M	61.67M	69.29M
Account Payables	342K	5.7M	7.66M	11.46M	11.94M	15.18M	12.73M	10.16M	3.77M	3.27M	1.89M	499.67K
Deferred Revenue	164K	n/a	13.32M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	95.1K	n/a	n/a	n/a	n/a
Other Current Liabilities	4.46M	1.71M	13.76M	2.46M	2.69M	3.76M	5.15M	3.39M	710.86K	509.99K	298.05K	86.11K
Total Current Liabilities	8.46M	9.62M	24.26M	14.89M	15.89M	20.68M	18.01M	14.01M	5.82M	3.97M	2.47M	966.56K
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	74.53K	n/a	n/a	43.87M	87.73M
Other Long-Term Liabilities	632K	n/a	n/a	161.64K	n/a	286.00	784K	-74.53K	317.33M	91.9M	45.89M	-128.46K
Total Long-Term Liabilities	656K	467K	585K	483.64K	911.83K	1.05M	810.73K	74.53K	317.38M	93.35M	90.54M	87.73M
Total Liabilities	9.12M	10.09M	24.85M	15.37M	16.81M	21.73M	18.82M	14.09M	323.2M	97.33M	93.01M	88.7M
Total Debt	178K	325K	465K	592.68K	437.88K	561.91K	124.52K	169.63K	139.86K	127.96K	43.93M	87.73M
Common Stock	10K	10K	10K	9.11K	9.64K	9.85K	10.36K	10.21K	3.68K	3.05K	3.13K	3.21K
Retained Earnings	-345.36M	-531.7M	-539.35M	-467.52M	-463.76M	-414.71M	-373.43M	-311.39M	-164.12M	-42.38M	-30.62M	-18.86M
Comprehensive Income	-1.67M	13.48M	-7.88M	13.76M	10.39M	3.85M	-6.48M	-3.17M	-259.35K	-7.07M	-6.72M	-6.37M
Shareholders Equity	92.17M	110.48M	101.04M	128.32M	160.21M	213.29M	272.57M	322.03M	-157.01M	-43.27M	-31.34M	-19.41M
Total Investments	15.48M	67K	12.65M	49.82M	84.27M	71.67M	n/a	n/a	2M	4.44M	2.41M	371.01K